CREBBP and neoplasm: These results further support our hypothesis that specific downregulation of Wnt/CBP/β-catenin signaling along with reprogramming of the TME may enhance the efficacy of tumor immunotherapy, increase recruitment of host T-cells, and improve immunotherapy to solid tumors (50).